Belumosudil with ROCK-2 inhibition: chemical and therapeutic development to FDA approval for the treatment of chronic graft-versus-host disease
Faraat Ali, Anam Ilyas
Topics & Concepts
MedicineOrphan drugClinical trialAdverse effectDrug developmentDisease registryDiseaseEuropean unionClinical researchDrugIntensive care medicineInternal medicinePharmacologyBioinformaticsEconomic policyBiologyBusinessHematopoietic Stem Cell TransplantationInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisAntifungal resistance and susceptibility